SYNEOS HEALTH
Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. We bring together approximately 24,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients.
SYNEOS HEALTH
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
1985-01-01
Address:
Morrisville, North Carolina, United States
Country:
United States
Website Url:
http://www.syneoshealth.com
Total Employee:
1001+
Status:
Active
Contact:
+1 919 876 9300
Total Funding:
524.65 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Acceleron Pharma
Acceleron is a biopharmaceutical company engaged in developing, manufacturing and commercializing novel biotherapeutics.
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Alphamab Oncology
Alphamab Oncology is a clinical-stage biopharmaceutical company dedicated to the discovery, development manufacturing and commercialization.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
FORMA Therapeutics
FORMA Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of transformative medicines.
Inovio Pharmaceuticals
Inovio is a biotech company focusing on bringing to market DNA medicines for diseases associated with HPV, cancer, and infectious diseases.
Parnell Living Science
Parnell is a fully integrated pharmaceutical company dedicated to finding animal health solutions that matter.
Pliant Therapeutics
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
Remedi SeniorCare
Remedi SeniorCare provides pharmacy services by offering automatic therapeutic interchange education and consulting and transition services.
Sharps Compliance
Sharps Compliance, Inc., based in Houston, Texas, is a leading developer and provider of superior solutions for improving safety
SurModics
SurModics provides a surface modification and in vitro diagnostic technologies to the healthcare industry.
Xeris Pharmaceuticals
Xeris Pharmaceuticals is a pharmaceutical company that develops therapies for patients in endocrinology, neurology, and gastroenterology.
XOMA
XOMA is at the forefront of antibody discovery and development, one of the most powerful and transformative fields of drug innovation
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-08-18 | Boco Digital Media | Boco Digital Media acquired by Syneos Health | N/A |
| 2021-10-06 | RxDataScience | RxDataScience acquired by Syneos Health | N/A |
| 2021-09-14 | StudyKIK | StudyKIK acquired by Syneos Health | N/A |
| 2020-12-18 | Illingworth Research | Illingworth Research acquired by Syneos Health | N/A |
| 2020-10-28 | Synteract | Synteract acquired by Syneos Health | N/A |
| 2018-08-20 | Kinapse | Kinapse acquired by Syneos Health | N/A |
| 2017-05-10 | inVentiv Health | inVentiv Health acquired by Syneos Health | 4.6 B USD |
| 2011-05-04 | Kendle International | Kendle International acquired by Syneos Health | 232 M USD |
Investors List
Thomas H. Lee Partners
Thomas H. Lee Partners investment in Private Equity Round - Syneos Health
Advent International
Advent International investment in Private Equity Round - Syneos Health
Adams Street Partners
Adams Street Partners investment in Venture Round - Syneos Health
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-09-24 | Elligo Health Research | Syneos Health investment in Series E - Elligo Health Research | 135 M USD |
| 2020-01-09 | Exeevo | Syneos Health investment in Venture Round - Exeevo | 20 M USD |
Newest Events participated
Participated in Partnerships in Clinical Trials Europe 2017
on 2017-11-28 as sponsor
Participated in FierceBiotech 2nd Drug Development Forum
on 2017-09-25 as sponsor
Participated in OrphanDrug Congress USA 2017
on 2017-04-19 as sponsor
Key Employee Changes
Official Site Inspections
http://www.syneoshealth.com Semrush global rank: 167.35 K Semrush visits lastest month: 491.9 K
- Host name: 104.18.34.168
- IP address: 104.18.34.168
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Syneos Health"
Who We Are - Syneos Health
Syneos Health ® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial …See details»
Syneos Health - Wikipedia
Syneos Health (formerly InVentiv Health Incorporated and INC Research) is an American company that provides contract research and commercial services to pharmaceutical and biotechnology companies. Based in Morrisville, North Carolina, the company specializes in helping other companies with late-stage clinical trials, but also provides commercial services to market health treatments. See details»
Syneos Health - LinkedIn
Syneos Health | 593,343 followers on LinkedIn. Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique ...See details»
Syneos Health Clinical Solutions | LinkedIn
Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights ...See details»
Syneos Health Commercial Solutions - LinkedIn
Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights ...See details»
Syneos Health - Crunchbase Company Profile & Funding
Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is …See details»
Shortening the distance from lab to life® - Syneos Health
Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial …See details»
Our Vision and Values - Syneos Health
Syneos Health ® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern …See details»
Syneos Health | Clinical Trials Montreal and Quebec
Created through the merger of two industry leading companies – INC Research and inVentiv Health – we bring together approximately 27,000 clinical and commercial minds with the ability to support customers in more than 110 …See details»
Careers - Syneos Health
3 days ago Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs …See details»
Syneos Health - Careers
We are a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success, which means you’ll have endless opportunities to work with experts around …See details»
Syneos Health Company Profile 2024: Valuation, Funding
Syneos Health General Information Description. Provider of biopharmaceutical research services catering to pharmaceutical and biotechnology firms. The company offers clinical services from …See details»
Syneos Health to be Acquired by a Private Investment Consortium …
MORRISVILLE, N.C., May 10, 2023 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (Nasdaq: SYNH) (“Syneos Health” or the “Company”), a leading fully integrated biopharmaceutical …See details»
Our Leadership - Syneos Health
Syneos Health ® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial …See details»
Biopharma Solutions - Syneos Health
Syneos Health ® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial …See details»
Working at Syneos Health - Glassdoor
Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial …See details»
Syneos Health to be Acquired by a Private Investment Consortium …
May 10, 2023 Shareholders to Receive $43.00 Per Share in Cash. Represents 24% Premium to Unaffected Stock Price. MORRISVILLE, N.C., May 10, 2023 (GLOBE NEWSWIRE) -- Syneos …See details»
Syneos Health Reports Second Quarter 2021 Results
An archived replay of the conference call is expected to be available online at investor.syneoshealth.com after 1:00 p.m. ET on August 9, 2021. About Syneos Health …See details»
Syneos Health Reports Fourth Quarter and Full Year 2022 Results
A webcast replay will be available on the Investor Relations section of the Syneos Health website at investor.syneoshealth.com after 1:00 p.m. on February 16, 2023. About Syneos Health. …See details»